Dexcom’s Next-Generation G7 Device Clearance Snagged

Dexcom’s pathway to FDA clearance for its next-generation Dexcom G7 continuous glucose monitoring system has hit a software snag, the company said.

In response to feedback from the agency, the company has been tweaking the supporting software and said it now expects the agency to make a decision on the submission later this year.

The latest Dexcom G7 features a smaller sensor than its predecessor, making it more convenient to monitor and manage glucose in diabetes patients.

The device has already received CE-mark certification in Europe.